Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Illumicell
AddedFeb 15, 2024
UpdatedJun 18, 2026
Illumicell

Illumicell

Seed

Massachusetts-based software company providing AI-powered male fertility screening tools.

HQ
Allston-Brighton, MA, US
Founded
2023
Overview
Compare
Fundraising
Employees
Website

Illumicell, founded by Michel Bielecki, Jeyla Sadikova, and Loup Cordey, is a Massachusetts-based software company specializing in AI-powered male fertility screening tools. Their core mission is to make advanced fertility care accessible and affordable, leveraging cutting-edge AI and space technology to provide precise and reliable fertility assessments for clinics and healthcare providers. By focusing on male fertility, Illumicell aims to fill a critical gap in reproductive health services.

Notable team members include Chief AI Officer Javier Barranco, PhD, and Optical Systems Engineer Anna Kuzmina, PhD. Illumicell has garnered significant attention, joining the Harvard LLX GEO cohort and earning a spot at the Techstars DeepTech accelerator. These achievements underscore their innovative approach and potential impact on the fertility care market, positioning them as a transformative player in the healthcare technology landscape.

Illumicell - Similar Companies

BioticsAI logo

BioticsAI

biotics.ai

Pera Labs logo

Pera Labs

peralabs.co

Alife logo

Alife

alifehealth.com

Life Whisperer logo

Life Whisperer

lifewhisperer.com

Lilia logo

Lilia

hellolilia.com

Iluma logo

Iluma

getiluma.ai

Conceivable Life Sciences logo

Conceivable Life Sciences

conceivable.life

Pregmune logo

Pregmune

pregmune.com

Univfy logo

Univfy

univfy.com

Legacy logo

Legacy

givelegacy.com

ONTO Health logo

ONTO Health

onto.health

Cellens logo

Cellens

cellensinc.com

BelleTorus logo

BelleTorus

belle.ai

MedAnswers logo

MedAnswers

Ainnova Tech logo

Ainnova Tech

ainnovatech.com

Illumicell - Quick Facts

Who are Illumicell's competitors?

Companies similar to Illumicell include BioticsAI, Pera Labs, Alife and Life Whisperer.

When was Illumicell founded?

Illumicell was founded in 2023.

Where is Illumicell's headquarters located?

Illumicell's headquarters is located in Allston-Brighton, MA, US.

When was Illumicell's last funding round?

Illumicell's most recent funding round was for $300k (USD) in November 2023.

How much has Illumicell raised to-date?

As of Nov 1, 2023, Illumicell has raised a total of $320k (USD).

How many employees does Illumicell have?

Illumicell has 5 employees as of Feb 4, 2024.

Illumicell - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Analytics
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Main Product
  • Fertility Screening
Tags
  • Healthcare
  • Healthtech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software